Evidence map›Paper›PMID 23908061›Full record

Trial reportStroke2013

Reduction in early stroke risk in carotid stenosis with transient ischemic attack associated with statin treatment.

Áine Merwick, Gregory W Albers, Ethem M Arsava, Hakan Ay, David Calvet, Shelagh B Coutts, Brett L Cucchiara, Andrew M Demchuk, Matthew F Giles, Jean-Louis Mas and 7 more

Open access · bronzeAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Stroke, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. 2025 Egyptian guidelines for the management of dyslipidemia.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Hypertriglyceridemia and Atherosclerotic Carotid Artery Stenosis.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Review
  11. Carotid Endarterectomy.Advances and technical standards in neurosurgery · 2022
    Article
  12. Article
  13. Development and Internal Validation of a Risk Score to Detect Asymptomatic Carotid Stenosis.European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 2 countries.

Áine MerwickFrom the Neurovascular Unit for Translational and Therapeutics Research, Stroke Service and Department of Neurology, Mater Misericordiae University Hospital/Dublin Academic Medical Centre, Dublin, Ireland (Á.M., P.J.K.); Department of Neurology and Neurological Sciences, Stanford Stroke Centre, Palo Alto, CA (G.W.A., J.M.O.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA (E.M.A., H.A.); Department of Neurology, Sainte-Anne Hospital, Paris Descartes University, Paris, France (D.C., J.-L.M.); Department of Clinical Neurosciences, and Radiology, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada (S.B.C., A.M.D.); Department of Neurology, University of Pennsylvania Medical Center, Philadelphia, PA (B.L.C.); Stroke Prevention Research Unit, John Radcliffe Hospital, Oxford, United Kingdom (M.F.G., P.M.R.); Stroke Unit, Department of Neurology, Hospitalt Universitari Arnau de Vilanova de Lleida and Universitat de Lleida, Biomedical Research Institute of Lleida, Lleida, Spain (F.P.); Department of Neurology, UCLA Stroke Center (J.L.S.); Division of Neurology, YLL School of Medicine, National University of Singapore and National University Hospital, Singapore, Singapore (V.K.S.); Second Department of Neurology, University of Athens, School of Medicine, Athens, Greece (G.T.); Department of Neurology, International Clinical Research Center, St. Anne's University Hospital in Brno, Brno, Czech Republic (G.T.); and Department of Neurology, Democritus University of Thrace, Alexandroupolis, Greece (G.T.).
Gregory W Albers
Ethem M Arsava
Hakan Ay
David Calvet
Shelagh B Coutts
Brett L Cucchiara
Andrew M Demchuk
Matthew F Giles
Jean-Louis Mas
Jean Marc Olivot
Francisco Purroy
Peter M Rothwell
Jeffrey L Saver
Vijay K Sharma
Georgios Tsivgoulis
Peter J Kelly
Université Paris Cité · FR

Funding

Circle of Willis variability and migraineR01NS061572 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI CUCCHIARA, BRETT LEE · 2007 to 2010
$1.4M
CIHR MOP-118096Medical Research Council G0500987NINDS NIH HHS R01 NS061572NINDS NIH HHS R0I- NS61572PHS HHS R0I-N5059710The Dunhill Medical Trust OSRP2/1006Wellcome Trust 095626
6 · The paper itself

Abstract

background and purposeStatins reduce stroke risk when initiated months after transient ischemic attack (TIA)/stroke and reduce early vascular events in acute coronary syndromes, possibly via pleiotropic plaque stabilization. Few data exist on acute statin use in TIA. We aimed to determine whether statin pretreatment at TIA onset modified early stroke risk in carotid stenosis.

methodsWe analyzed data from 2770 patients with TIA from 11 centers, 387 with ipsilateral carotid stenosis. ABCD2 score, abnormal diffusion weighted imaging, medication pretreatment, and early stroke were recorded.

resultsIn patients with carotid stenosis, 7-day stroke risk was 8.3% (95% confidence interval [CI], 5.7-11.1) compared with 2.7% (CI, 2.0%-3.4%) without stenosis (P<0.0001; 90-day risks 17.8% and 5.7% [P<0.0001]). Among carotid stenosis patients, nonprocedural 7-day stroke risk was 3.8% (CI, 1.2%-9.7%) with statin treatment at TIA onset, compared with 13.2% (CI, 8.5%-19.8%) in those not statin pretreated (P=0.01; 90-day risks 8.9% versus 20.8% [P=0.01]). Statin pretreatment was associated with reduced stroke risk in patients with carotid stenosis (odds ratio for 90-day stroke, 0.37; CI, 0.17-0.82) but not nonstenosis patients (odds ratio, 1.3; CI, 0.8-2.24; P for interaction, 0.008). On multivariable logistic regression, the association remained after adjustment for ABCD2 score, smoking, antiplatelet treatment, recent TIA, and diffusion weighted imaging hyperintensity (adjusted P for interaction, 0.054).

conclusionsIn acute symptomatic carotid stenosis, statin pretreatment was associated with reduced stroke risk, consistent with findings from randomized trials in acute coronary syndromes. These data support the hypothesis that statins started acutely after TIA symptom onset may also be beneficial to prevent early stroke. Randomized trials addressing this question are required.

Indexed as

AgedAged, 80 and overBrain IschemiaCarotid StenosisDiffusion Magnetic Resonance ImagingFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiddle AgedRadiographyRisk FactorsStrokeTime FactorsHydroxymethylglutaryl-CoA Reductase Inhibitorscarotid stenosisischemic attack, transientstatin

Identifiers

PMID23908061
PMCPMC3871879
OpenAlexW2114083140

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.